elmundo.es
🌐 85% Global Worthiness
18-Year Cancer Remission Achieved with First-Generation CAR-T Therapy in Neuroblastoma Patient
An 18-year cancer remission in a neuroblastoma patient treated with first-generation CAR-T cell therapy at age four has been reported, exceeding previous remission records for both hematological and solid cancers, highlighting the therapy's potential for broader applications.
18-Year Cancer Remission Achieved with First-Generation CAR-T Therapy in Neuroblastoma Patient
An 18-year cancer remission in a neuroblastoma patient treated with first-generation CAR-T cell therapy at age four has been reported, exceeding previous remission records for both hematological and solid cancers, highlighting the therapy's potential for broader applications.
Progress
44% Bias Score
Good Health and Well-being